Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors (GEP-NET) account for roughly 60% of all neuroendocrine tumors, and low/intermediate grade human GEP-NETs have relatively slow growth rates that many laboratory culture methods fail to capture. Patient-derived cancer organoids (PDCOs) are...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillette, Amani A., Babiarz, Christopher P., VanDommelen, Ava R., Pasch, Cheri A., Clipson, Linda, Matkowskyj, Kristina A., Deming, Dustin A., Skala, Melissa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070804/
https://www.ncbi.nlm.nih.gov/pubmed/33919802
http://dx.doi.org/10.3390/cancers13081873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070804/
https://www.ncbi.nlm.nih.gov/pubmed/33919802
http://dx.doi.org/10.3390/cancers13081873

Ejemplares similares